Physician profile
John R Thanus
NPI 1083602320
$6,392.96
in general payments reported to CMS, 2019-2025
35 companies · $858 in 2025
The $858 reported for 2025 was more than what 89% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,392 · 2020: $637 · 2021: $576 · 2022: $960 · 2023: $1,021 · 2024: $949 · 2025: $858.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,828.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,827.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,047.74 | 2019-2025 | Evenity, Prolia |
| Abbvie INC. | $856.22 | 2019-2023 | Lo Loestrin Fe, Liletta |
| Mayne Pharma Commercial LLC | $547.47 | 2021-2025 | |
| Exeltis, USA INC. | $390.80 | 2020-2025 | Slynd |
| Hologic Sales and Service, LLC | $322.08 | 2019-2025 | Thinprep 2000 Processor |
| Sumitomo Pharma America, INC. | $276.21 | 2023-2025 | Myfembree |
| Pfizer INC. | $244.36 | 2020-2024 | |
| Organon LLC | $241.65 | 2021-2025 | Nexplanon |
| Myovant Sciences INC. | $235.58 | 2021-2022 | |
| Lupin INC. | $226.02 | 2019-2021 | |
| Evofem Biosciences, INC. | $211.97 | 2021-2025 | Phexxi, Solosec, Phexx |
| Coopersurgical, INC. | $199.93 | 2020-2025 | Paragard T 380a, Paragard T 380a |
| Merck Sharp & Dohme LLC | $178.23 | 2021-2025 | Gardasil 9, Gardasil |
| Millicent US INC | $165.59 | 2024-2025 | Femlyv, Intrarosa |
| Biogen, INC. | $157.24 | 2024-2025 | Zurzuvae |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $113.63 | 2019 | |
| Astellas Pharma US INC | $106.88 | 2023-2025 | Veozah |
| Agile Therapeutics, INC. | $102.24 | 2021-2024 | Twirla |
| Avion Pharmaceuticals | $92.84 | 2019-2022 | |
| Therapeuticsmd, INC. | $91.71 | 2019-2022 | |
| Daiichi Sankyo INC. | $87.91 | 2019-2024 | Injectafer |
| Bayer Healthcare Pharmaceuticals INC. | $74.31 | 2019-2023 | |
| Scynexis, INC. | $52.30 | 2022 | |
| Octapharma USA, INC. | $48.64 | 2024 | Fibryga |
| Amag Pharmaceuticals, INC. | $46.79 | 2019-2020 | |
| Shield Therapeutics INC | $46.07 | 2024-2025 | |
| Allergan, INC. | $38.15 | 2019 | |
| Roche Diagnostics Corporation | $35.87 | 2019 | |
| Vertical Pharmaceuticals, LLC | $35.28 | 2019 | |
| Smith+Nephew, INC. | $24.82 | 2025 | Allevyn Heel 10.5cm X 13.5cm Ctn 5 |
| Exact Sciences Corporation | $24.13 | 2024 | Cologuard Collection Kit |
| Meditrina | $23.02 | 2023 | |
| Aspira Women'S Health INC | $17.00 | 2020 | |
| Duchesnay USA Incorporated | $16.34 | 2019 | |
| Mission Pharmacal Company | $13.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Thanus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.